Table 4

The relationship between KSQ and disease-specific outcome measures

Generic QOLFatigueLungSkinEye
SF36FASFVCSGRQMRCDLQIPGAVFQ-25VA
PCSMCSTotal% PredSymActImpTotBreathlessnessTotalTotal
KSQ modules
 General health status0.640.70−0.86−0.49−0.67−0.66−0.70−0.57−0.350.66
 Lung0.710.39−0.600.47−0.74−0.78−0.78−0.85−0.58
 Skin0.32*0.47**−0.42**−0.67−0.53
 Eye0.56**0.55**−0.590.80−0.56**
 Medication0.25*0.29**−0.35−0.31**−0.33−0.41−0.40−0.29−0.380.27*
Overall Health Status
 Lung+GHS0.730.62−0.820.49−0.66−0.78−0.77−0.83−0.62
 Skin+GHS0.580.69−0.78−0.48**−0.38*
 Eye+GHS0.600.66−0.820.80−0.45**
 Lung+Skin+GHS0.700.63−0.790.45−0.65−0.79−0.76−0.83−0.64−0.47**−0.38*
  • Data shown are Pearson's correlation coefficients for organ-specific comparisons. All p<0.001 (stronger evidence of association) except **p<0.01 and ≥0.001 (some evidence of association) and *p<0.05 and >0.01 (possibly due to chance or only suggestive of association).

  • Act, activity; DLQI, Dermatology Life Quality Index; FAS, Fatigue Assessment Scale; FVC, forced vital capacity; HS, health status; Imp, impact; KSQ, King's Sarcoidosis Questionnaire; MRC, Medical Research Council dyspnoea scale; PGA, Physicians Global Assessment; SGRQ, St George's Respiratory Questionnaire—Symptoms; Sym, symptoms; Tot, total; SF-36 PCS, Short Form 36 Physical Component Summary; SF-36 MCS, Short Form 36 Mental Component Summary; VA, visual acuity; VFQ-25, Visual Function Questionnaire (25 items); –, not applicable.